MedTrace Logo

Mohs Micrographic Surgery and Reconstruction in the Optum Insurance Claims Database

NCT04117373 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-03-06

No results posted yet for this study

Summary

Mohs micrographic surgery (MMS) followed by skin reconstruction has been widely accepted for treatment of many skin cancers. To further characterize the trends in MMS and reconstruction for skin cancer, a retrospective analysis will be performed using the Optum© Clinformatics® DataMart de-identified commercial claims database from 2001-2016. The findings may provide critical data for future prospective studies in skin cancer treatments.

Conditions

  • Skin Cancer
  • Mohs Micrographic Surgery
  • Interpolated Flap Repair

Sponsors & Collaborators

Principal Investigators

  • Jeremy Etzkorn, MD · University of Pennsylvania

Eligibility

Min Age
1 Year
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04117373 on ClinicalTrials.gov